Detection of Rare Antimicrobial Resistance Profiles by Active and Passive Surveillance Approaches

Antimicrobial resistance (AMR) surveillance systems are generally not specifically designed to detect emerging resistances and usually focus primarily on resistance to individual drugs. Evaluating the diversity of resistance, using ecological metrics, allows the assessment of sampling protocols with regard to the detection of rare phenotypes, comprising combinations of resistances. Surveillance data of phenotypic AMR of Canadian poultry Salmonella Heidelberg and swine Salmonella Typhimurium var. 5- were used to contrast active (representative isolates derived from healthy animals) and passive (diagnostic isolates) surveillance and assess their suitability for detecting emerging resistance patterns. Although in both datasets the prevalences of resistance to individual antimicrobials were not significantly different between the two surveillance systems, analysis of the diversity of entire resistance phenotypes demonstrated that passive surveillance of diagnostic isolates detected more unique phenotypes. Whilst the most appropriate surveillance method will depend on the relevant objectives, under the conditions of this study, passive surveillance of diagnostic isolates was more effective for the detection of rare and therefore potentially emerging resistance phenotypes.

[1]  W. Sischo,et al.  Antimicrobial Resistance Profiles and Diversity in Salmonella from Humans and Cattle, 2004–2011 , 2015, Zoonoses and public health.

[2]  Alan P. Johnson.  Surveillance of antibiotic resistance , 2015, Philosophical Transactions of the Royal Society B: Biological Sciences.

[3]  L. Matthews,et al.  An ecological approach to assessing the epidemiology of antimicrobial resistance in animal and human populations , 2012, Proceedings of the Royal Society B: Biological Sciences.

[4]  R. Davies,et al.  Longitudinal survey of the occurrence of Salmonella in pigs and the environment of nucleus breeder and multiplier pig herds in England , 2009, Veterinary Record.

[5]  K. Laupland,et al.  Surveillance for antimicrobial resistant organisms: potential sources and magnitude of bias , 2009, Epidemiology and Infection.

[6]  P. Hawkey,et al.  The growing burden of antimicrobial resistance. , 2008, The Journal of antimicrobial chemotherapy.

[7]  D. Church,et al.  Investigation of sources of potential bias in laboratory surveillance for anti-microbial resistance. , 2007, Clinical and investigative medicine. Medecine clinique et experimentale.

[8]  G. Bell,et al.  Genotypic diversity and antimicrobial resistance in asymptomatic Salmonella enterica serotype Typhimurium DT104. , 2007, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[9]  J. Verhaegen,et al.  Epidemiologic Features of Invasive Pneumococcal Disease in Belgian Children: Passive Surveillance Is Not Enough , 2006, Pediatrics.

[10]  F. Aarestrup,et al.  Priorities for antibiotic resistance surveillance in Europe. , 2006, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[11]  R. Cantón,et al.  Role of the microbiology laboratory in infectious disease surveillance, alert and response , 2005, Clinical Microbiology and Infection.

[12]  A. Rajić,et al.  Antimicrobial resistance of selected Salmonella isolates from food animals and food in Alberta. , 2005, The Canadian veterinary journal = La revue veterinaire canadienne.

[13]  F. Aarestrup.  Monitoring of antimicrobial resistance among food animals: principles and limitations. , 2004, Journal of veterinary medicine. B, Infectious diseases and veterinary public health.

[14]  A. Smith,et al.  Age at primary infection with Salmonella enterica serovar Typhimurium in the chicken influences persistence of infection and subsequent immunity to re-challenge. , 2004, Veterinary immunology and immunopathology.

[15]  J. Karlowsky,et al.  Optimal use of antibiotic resistance surveillance systems. , 2004, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[16]  Marc Lipsitch,et al.  Projected benefits of active surveillance for vancomycin-resistant enterococci in intensive care units. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  Barry G. Hall,et al.  Evolution of the serine β-lactamases: past, present and future , 2004 .

[18]  L. Audigé,et al.  Monitoring and surveillance for rare health-related events: a review from the veterinary perspective. , 2001, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[19]  V. Isham,et al.  Surveillance of antimicrobial resistance--what, how and whither? , 2001, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[20]  R. Masterton.  Surveillance studies: how can they help the management of infection? , 2000, The Journal of antimicrobial chemotherapy.

[21]  A. Caprioli,et al.  Monitoring of antibiotic resistance in bacteria of animal origin: epidemiological and microbiological methodologies. , 2000, International journal of antimicrobial agents.

[22]  R. Anderson.  The pandemic of antibiotic resistance , 1999, Nature Medicine.

[23]  A. MacGowan,et al.  Surveillance of antimicrobial resistance , 1998, The Lancet.

[24]  D. Livermore,et al.  Surveillance of antimicrobial resistance , 1998, BMJ.

[25]  F. Tenover,et al.  Surveillance for the emergence and dissemination of antimicrobial resistance in bacteria. , 1997, Infectious disease clinics of North America.

[26]  Frank M. Aarestrup,et al.  Monitoring of Antimicrobial Resistance in Animals: Principles and Practices , 2019, Antimicrobial Resistance in Bacteria of Animal Origin.

[27]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[28]  K. Stärk,et al.  Evaluation and optimization of surveillance systems for rare and emerging infectious diseases , 2008 .

[29]  Miriam Barlow,et al.  Evolution of the serine beta-lactamases: past, present and future. , 2004, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[30]  J. Tapsall.  Monitoring antimicrobial resistance for public health action. , 2003, Communicable diseases intelligence quarterly report.

[31]  G. French,et al.  Antibiotic resistance: effect of different criteria for classifying isolates as duplicates on apparent resistance frequencies. , 2002, The Journal of antimicrobial chemotherapy.

[32]  Deirdre Lewis,et al.  Antimicrobial resistance surveillance: methods will depend on objectives. , 2002, The Journal of antimicrobial chemotherapy.

[33]  P. Michel,et al.  Trends in antimicrobial resistance of Salmonella isolated from animals, foods of animal origin, and the environment of animal production in Canada, 1994-1997. , 2001, Microbial drug resistance.

[34]  L. Stark,et al.  Dengue surveillance in Florida, 1997-98. , 2000, Emerging infectious diseases.